Cargando…
Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis
Ovarian cancer represents one of the most malignant gynecological cancers worldwide, with an overall 5-year survival rate, being locked in the 25–30% range in the last decade. Cancer immunotherapy is currently one of the most intensively investigated and promising therapeutic strategy and as such, i...
Autores principales: | Bruno, Antonino, Noonan, Douglas M., Valli, Roberto, Porta, Giovanni, Taramelli, Roberto, Mortara, Lorenzo, Acquati, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409134/ https://www.ncbi.nlm.nih.gov/pubmed/36012339 http://dx.doi.org/10.3390/ijms23169074 |
Ejemplares similares
-
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
por: Acquati, Francesco, et al.
Publicado: (2019) -
Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase
por: Lualdi, Marta, et al.
Publicado: (2015) -
A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling
por: Roggiani, Francesca, et al.
Publicado: (2019) -
Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection
por: De Vito, Annarosaria, et al.
Publicado: (2020) -
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells
por: Acquati, Francesco, et al.
Publicado: (2011)